The number of potential antimicrobial treatments being developed by the world’s largest drugmakers nosedived by 35% over the past five years, according to a new analysis.
Theresa Gaffney is the lead Morning Rounds writer and reports on health care, new research, and public policy, with a particular interest in mental health, gender-affirming care, and LGBTQ+ patient ...
Ugur Sahin and Özlem Türeci, the couple who co-founded BioNTech, are leaving the Covid-19 vaccine maker to start a new, mRNA-focused firm.
The FDA has sharply cut back on public advisory committee meetings, and this morning STAT’s Lizzy Lawrence explains what ...
Novo Nordisk and Hims & Hers have reached a deal that, for now, appears to end their bitter dispute around Hims’ sale of compounded versions of Novo’s blockbuster obesity drug Wegovy.
As the Super Bowl approached halftime, Hims & Hers publicly staked its claim to preventive medicine in front of the American people. In a one-minute ad, the direct-to-consumer health company ...
Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. Several years ago, nephrologists attempted a first-of-its-kind effort ...
Vertex said a drug it secured as part of a $4.9 billion acquisition successfully reduced by half a key marker of a kidney disease known as IgA nephropathy.
A battle between doctors and a hospital system is an early test of a new law designed to separate business and medicine.
Parents often pressure Lawrence Diller, a behavioral/developmental pediatrician, to diagnose their children with autism. He thinks he knows why.
PeaceHealth's move to replace ER doctors with ApolloMD clinicians is testing a new state law limiting corporate medicine.
With the drop in overdose deaths, “we're celebrating: a death toll that exceeds total American combat fatalities in Vietnam, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results